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Abstract Cardiacmyosinbindingprotein-C(cMyBP-C)is
an accessory protein found in the A-bands of vertebrate
sarcomeres and mutations in the cMyBP-C gene are a lead-
ing cause of familial hypertrophic cardiomyopathy. The
regulatoryfunctionsofcMyBP-Chavebeenattributedtothe
N-terminus of the protein, which is composed of tandem
immunoglobulin (Ig)-like domains (C0, C1, and C2), a
region rich in proline and alanine residues (the Pro-Ala rich
region) that links C0and C1, and a unique sequence referred
toas the MyBP-C motif, orM-domain, that links C1and C2.
Recombinant proteins that contain various combinations of
the N-terminal domains of cMyBP-C can activate actomy-
osin interactions in the absence of Ca
2?, but the speciﬁc
sequences required for these effects differ between species;
the Pro-Ala region has been implicated in human cMyBP-C
whereas the C1 and M-domains appear important in mouse
cMyBP-C. To investigate whether species-speciﬁc differ-
encesinsequencecanaccountfortheobserveddifferencesin
function, we compared sequences of the Pro-Ala rich region
incMyBP-Cisoformsfromdifferentspecies.Herewereport
thatthenumberofprolineandalanineresiduesinthePro-Ala
richregionvariessigniﬁcantlybetweendifferentspeciesand
that the number correlates directly with mammalian body
sizeandinverselywithheartrate.Thus,systematicsequence
differences in the Pro-Ala rich region of cMyBP-C may
contribute to observed functional differences in human
versus mouse cMyBP-C isoforms and suggest that the Pro-
Alaregionmaybeimportantinmatchingcontractilespeedto
cardiac function across species.
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Introduction
Myosin binding protein-C (MyBP-C) is a regulatory and
structural protein located in the A-bands of vertebrate
striated muscle sarcomeres. The N-terminus of cardiac (c)
MyBP-C is important for mediating the regulatory func-
tions of cMyBP-C and is composed of 3 immunoglobulin
(Ig)–like domains (C0, C1, and C2), a region rich in Pro
and Ala residues (the Pro-Ala rich region) that links C0 and
C1, and the unique MyBP-C motif (M-domain) that links
the C1 and C2 domains. The N-terminal domains act to
regulate actomyosin interactions by accelerating cross-
bridge cycling rates (Stelzer et al. 2007) through phos-
phorylation-mediated interactions potentially between the
M-domain and myosin S2 (Kunst et al. 2000) and/or actin
(Shaffer et al. 2009). In addition, recombinant N-terminal
domains of cMyBP-C can activate tension generation and
increase the rate of force redevelopment (ktr) in perme-
abilized myocytes in the absence of Ca
2? (Herron et al.
2006; Razumova et al. 2008).
Whereas the ability of the N-terminus of cMyBP-C to
inﬂuence actomyosin interactions has been reported by
several groups (Kulikovskaya et al. 2003; Herron et al.
2006; Razumova et al. 2006; Stelzer et al. 2007; Razumova
et al. 2008), the speciﬁc domains and mechanisms required
for functional effects are more controversial. For example,
Herron et al. (2006) showed that the recombinant human
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rich region, and C1 domains) activated tension and
increased ktr in skinned human ventricular myocytes in
the absence of Ca
2? and concluded that the Pro-Ala rich
region was required for the activating effects. By contrast,
Razumova et al. (2008) demonstrated that mouse C1C2
(which includes the C1, M, and C2 domains) activated
tension and increased ktr in skinned rat trabeculae, whereas
C0C1 (including the Pro-Ala rich region) had no effect.
These authors concluded that the C1 and M domains were
essential for the activating effects.
The different conclusions reached in the two studies could
potentially be explained by species-speciﬁc differences
between the N-terminal domains of mouse and human
cMyBP-C. Consistent with this, chimeric proteins containing
mouseorhumanN-terminaldomainshavedifferentialeffects
onactomyosininteractions(Shafferetal.2010).WhiletheC0,
C1, M, and C2 domains all share greater than 80% identity
between human and mouse isoforms (withthe C1, M, and C2
domains each[90% identical), the Pro-Ala rich regions of
human and mouse cMyBP-C are less well conserved—only
46% of the amino acids are identical. The major difference
between the Pro-Ala rich regions of human and mouse
cMyBP-C is the number of proline and alanine residues—the
mouse Pro-Ala rich region is composed of 28.2% proline and
alanine residues, while the human isoform contains 51.0%
(Fig. 1a; Table 1). In addition, the Pro-Ala rich region of
human cMyBP-C has been proposed to bind to actin (Squire
etal.2003),whilethemousePro-Alarichregionmaynotbind
actin or may only bind weakly (Shaffer et al. 2009). Thus,
differencesinthenumberofprolineandalanineresiduesinthe
human and mouse Pro-Ala rich regions and potential differ-
ences in actin binding interactions suggest that sequence dif-
ferencesinthe Pro-Alarichregions ofcMyBP-C canaccount
for the observed functional differences.
The purpose of the current study was to perform a sys-
tematic comparison of the Pro-Ala rich sequences in differ-
ent species. By comparing cMyBP-C sequence data, we
demonstrate that the length of the Pro and Ala region is not
conserved and that the Pro-Ala content varies in different
species. Furthermore, the number of proline and alanine
residues correlates directly with body weight and inversely
with heart rate in mammals. These ﬁndings raise the
intriguingpossibilitythatthePro-AlarichregionofcMyBP-
Cscales inconcertwithmechanismsthatﬁne-tune thespeed
of contraction to match cardiac function in different species.
The Pro-Ala rich region of cMyBP-C varies with heart
rate in mammals
Protein sequence data for 15 species isoforms of cMyBP-C
were downloaded from GenBank (Benson et al. 2009)o r
Ensembl (Hubbard et al. 2009) databases and sequences
were aligned and compared using CLUSTALX 2.0.10
(Larkin et al. 2007). To compare Pro-Ala regions, the Pro-
Ala rich region of human cMyBP-C was used as reference
with domain boundaries for the 51 amino acid sequence
determined as described by Gautel et al. (1995) and the
Universal Protein Resources Databank (UniProt) (Jain
et al. 2009). The Pro-Ala rich regions for the remaining
sequences were determined using sequence homology to
the human isoform. The percentage of Pro and Ala residues
in each Pro-Ala rich region was calculated by dividing the
number of Pro and Ala residues in the region of homology
by the total number of amino acids in the entire Pro-Ala
sequence.
Table 1 shows results of sequence comparisons of the
cMyBP-C Pro-Ala regions of 15 species, including repre-
sentative sequences from mammals, aves, amphibians, and
ﬁsh. The total length of the Pro-Ala region and the per-
centage of Pro and Ala residues in the sequence were not
conserved but varied across all the species examined. The
longest Pro-Ala sequence occurred in Zebraﬁsh (62 amino
acids), whereas the shortest Pro-Ala region occurred in
chicken (41 amino acids). The percentage of Pro-Ala res-
idues varied from * 25% (rat) to * 53% (Xenopus).
Trends across different phyla were not apparent, but the
Fig. 1 a Seqeunce alignment of human and mouse Pro-Ala rich
regions. Asterisks denote identical residues. b Relationship between
average resting heart rate and the percentage of Pro and Ala residues
in the Pro-Ala rich region of mammalian cMyBP-C isoforms. Data
are shown for mouse, rat, guinea pig, rabbit, cat, dog, macaque
monkey, pig, dolphin, horse, cow, and human species. Heart rate data
are from (Spector 1956)
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lian species preclude a more deﬁnitive statement. By
contrast, a trend in mammals was noted where the percent
of proline and alanine residues correlated with body weight
such that species with greater body weights had the highest
percentage of Pro-Ala residues. Because body weight is
inversely correlated with heart rate (Schmidt-Nielsen
1997), we also plotted the percentage of Pro-Ala residues
as a function of heart rate. As shown in Fig. 1, the per-
centage of proline and alanine residues in the Pro-Ala rich
region was inversely correlated with heart rate (R
2 = 0.62).
Implications for the role of cMyBP-C in sarcomeres
Pro-Ala rich sequences have been identiﬁed in other thick
ﬁlament regulatory proteins including cardiac and skeletal
isoforms of myosin essential light chain (ELC). In these
proteins the Pro-Ala sequences modulate cross-bridge
cycling rates and shortening velocity (Vmax) through
mechanisms that involve binding of the ELCs to actin
(Andreev et al. 1999). It is possible that the Pro-Ala rich
region of cMyBP-C performs a similar role and contributes
to the ability of cMyBP-C to limit myocyte shortening
velocity, cross-bridge cycling, and power output (Korte
et al. 2003). If so, then graded changes in the content of the
Pro-Ala region described here could serve to optimize
power output (the product of force and velocity) such that
contractile efﬁciency is maximized in hearts that contract
under different hemodynamic loads and at different speeds.
Thus, changes in the Pro-Ala rich region of cMyBP-C may
act to accelerate cross-bridge cycling kinetics in small
mammals or slow cycling rates in larger mammals and
thereby ﬁne tune changes in cross-bridge cycling kinetics
that occur from isoform shifts in other contractile proteins
such as in myosin heavy chain that shifts from fast a-MHC
(high ATPase activity and crossbridge cycling) to slow
b-MHC (Pope et al. 1980; Schwartz et al. 1981; Morano
et al. 1988; Hamilton and Ianuzzo 1991).
The proline-alanine rich regions of different ELC iso-
forms are thought to slow cross-bridge kinetics either by
binding directly to actin (Trayer, Trayer et al. 1987)o rb y
functioning as a rigid spacer arm that extends an actin
binding site located near the N-terminus of the ELC out
toward the thin ﬁlament (Timson and Trayer 1997). In both
cases, interactions with actin serve to slow shortening
velocity and limit cross-bridge cycling (Sweeney 1995),
possibly by creating a drag that limits ﬁlament sliding.
Consistent with this idea, atrial myocytes that express an
atrial ELC isoform with reduced afﬁnity for actin have
greater Vmax and maximal power output than ventricular
myocytes expressing an ELC that binds to actin with
increased afﬁnity (Schaub et al. 1998). It remains to be
determined whether changes in the proline-alanine content
of cMyBP-C described here also affect actin binding
afﬁnity, but available data from different studies suggests
that proteins containing the human Pro-Ala sequence bind
actin with greater afﬁnity (Kulikovskaya et al. 2003) than
those containing the mouse sequence (Shaffer et al. 2009).
If so, reduced binding of the Pro-Ala sequence to actin
could contribute to accelerated cycling kinetics in mouse
hearts, whereas increased binding may slow cross-bridge
kinetics in human hearts or hearts from larger mammals.
Similarly, it will be of interest to determine whether the
actin binding afﬁnity of fast skeletal light chain (MLC1F)
varies by species since Bicer and Reiser (Bicer and Reiser
2007) found that the molecular weight of MLC1F
increased with increasing body mass in species from the
Table 1 Composition of the
cMyBP-C Pro-Ala rich region
in different species
The boundaries for the Pro-Ala
rich region were determined by
sequence homology to human
cMyBP-C using domain
boundaries described previously
(Gautel et al. 1995). Asterisks
denote sequences that were
predicted by comparing that
organism’s genome to the
human genome and have not yet
been veriﬁed by direct gene
cloning
Species Pro-Ala length % Pro & Ala Sequence identiﬁer Database
Human 51 51.0 NP_000247.2 Genbank
Cow 49 51.0 NP_001070004.1 Genbank
Horse 49 46.9 XP_001491151.2 Genbank*
Dolphin 49 44.9 ENSTTRP00000013421 Ensembl*
Pig 49 42.4 ENSSSCP00000014064 Ensembl*
Macaque 51 45.1 ENSMMUP00000020472 Ensembl*
Dog 55 43.6 NP_001041571.1 Genbank
Cat 49 32.7 ENSFCAP00000000303 Ensembl
Rabbit 52 51.9 ENSOCUP00000001825 Ensembl*
Guinea Pig 48 38.0 ENSCPOP00000012034 Ensembl*
Rat 52 25.0 NP_001099960.1 Genbank
Mouse 46 28.2 AF097333 Genbank
Chicken 41 48.8 NP_990447.1 Genbank
Tropical Frog 58 53.4 NP_001106379.1 Genbank
Zebraﬁsh 62 34.3 NP_001037814 Genbank
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sequence.
Conclusions
The goal of this study was to perform a sequence com-
parison of the Pro-Ala rich region of cMyBP-C in different
species. Results demonstrate that the sequence is not con-
served but varies in length and in the number of proline and
alanine residues. In mammals, the percentage of proline
and alanines correlated inversely with species resting heart
rate. By analogy with the proline-alanine rich sequences in
myosin essential light chains, we propose that the Pro-Ala
region of cMyBP-C slows cardiac cross-bridge cycling
kinetics. Species-speciﬁc differences in the Pro-Ala region
could thus account for functional differences observed in
proteins containing mouse or human Pro-Ala sequences
(Herron et al. 2006; Razumova et al. 2008; Shaffer et al.
2010) and thereby ﬁne-tune cross-bridge speed to match
cardiac function in hearts of different species.
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